Entheon Biomedical Corp Stock Buy Hold or Sell Recommendation
| ENTBF Stock | USD 0.17 0.06 26.09% |
Assuming the 90 days horizon and your typical level of risk aversion, our recommendation regarding Entheon Biomedical Corp is 'Sell'. Macroaxis provides Entheon Biomedical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ENTBF positions.
Check out Entheon Biomedical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Entheon and provide practical buy, sell, or hold advice based on investors' constraints. Entheon Biomedical Corp. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Entheon |
Execute Entheon Biomedical Buy or Sell Advice
The Entheon recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Entheon Biomedical Corp. Macroaxis does not own or have any residual interests in Entheon Biomedical Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Entheon Biomedical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Entheon Biomedical Trading Alerts and Improvement Suggestions
| Entheon Biomedical is way too risky over 90 days horizon | |
| Entheon Biomedical has some characteristics of a very speculative penny stock | |
| Entheon Biomedical appears to be risky and price may revert if volatility continues | |
| Entheon Biomedical Corp has accumulated 300 K in total debt with debt to equity ratio (D/E) of 0.05, which may suggest the company is not taking enough advantage from borrowing. Entheon Biomedical Corp has a current ratio of 0.95, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Entheon Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Entheon Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Entheon Biomedical Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Entheon to invest in growth at high rates of return. When we think about Entheon Biomedical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 21.67 K. Net Loss for the year was (8.89 M) with profit before overhead, payroll, taxes, and interest of 9.13 K. | |
| Entheon Biomedical Corp has accumulated about 467.58 K in cash with (5.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Entheon Biomedical Returns Distribution Density
The distribution of Entheon Biomedical's historical returns is an attempt to chart the uncertainty of Entheon Biomedical's future price movements. The chart of the probability distribution of Entheon Biomedical daily returns describes the distribution of returns around its average expected value. We use Entheon Biomedical Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Entheon Biomedical returns is essential to provide solid investment advice for Entheon Biomedical.
| Mean Return | 2.95 | Value At Risk | -20 | Potential Upside | 38.89 | Standard Deviation | 23.43 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Entheon Biomedical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Entheon Biomedical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Entheon Biomedical or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Entheon Biomedical's price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Entheon otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 3.19 | |
β | Beta against Dow Jones | 2.79 | |
σ | Overall volatility | 24.36 | |
Ir | Information ratio | 0.13 |
Entheon Biomedical Volatility Alert
Entheon Biomedical Corp is showing large volatility of returns over the selected time horizon. Entheon Biomedical Corp is a potential penny stock. Although Entheon Biomedical may be in fact a good instrument to invest, many penny otc stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Entheon Biomedical Corp. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Entheon instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Entheon Biomedical Fundamentals Vs Peers
Comparing Entheon Biomedical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Entheon Biomedical's direct or indirect competition across all of the common fundamentals between Entheon Biomedical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Entheon Biomedical or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Entheon Biomedical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Entheon Biomedical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Entheon Biomedical to competition |
| Fundamentals | Entheon Biomedical | Peer Average |
| Return On Equity | -0.55 | -0.31 |
| Return On Asset | -0.46 | -0.14 |
| Operating Margin | (60.27) % | (5.51) % |
| Current Valuation | 1.12 M | 16.62 B |
| Shares Outstanding | 59.09 M | 571.82 M |
| Shares Owned By Insiders | 8.63 % | 10.09 % |
| Price To Book | 0.22 X | 9.51 X |
| Price To Sales | 9.60 X | 11.42 X |
| Revenue | 21.67 K | 9.43 B |
| Gross Profit | 9.13 K | 27.38 B |
| EBITDA | (8.62 M) | 3.9 B |
| Net Income | (8.89 M) | 570.98 M |
| Cash And Equivalents | 467.58 K | 2.7 B |
| Cash Per Share | 0.01 X | 5.01 X |
| Total Debt | 300 K | 5.32 B |
| Debt To Equity | 0.05 % | 48.70 % |
| Current Ratio | 0.97 X | 2.16 X |
| Book Value Per Share | 0.11 X | 1.93 K |
| Cash Flow From Operations | (5.62 M) | 971.22 M |
| Earnings Per Share | (0.11) X | 3.12 X |
| Number Of Employees | 3 | 18.84 K |
| Beta | 1.89 | -0.15 |
| Market Capitalization | 1.3 M | 19.03 B |
| Total Asset | 9.98 M | 29.47 B |
| Z Score | 2.4 | 8.72 |
| Net Asset | 9.98 M |
Entheon Biomedical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Entheon . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.74 | |||
| Day Median Price | 0.17 | |||
| Day Typical Price | 0.17 | |||
| Price Action Indicator | (0.03) | |||
| Period Momentum Indicator | (0.06) |
About Entheon Biomedical Buy or Sell Advice
When is the right time to buy or sell Entheon Biomedical Corp? Buying financial instruments such as Entheon OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Entheon Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Mid Cap ETFs Thematic Idea Now
Mid Cap ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Mid Cap ETFs theme has 70 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Mid Cap ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Entheon OTC Stock
Entheon Biomedical financial ratios help investors to determine whether Entheon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entheon with respect to the benefits of owning Entheon Biomedical security.